Randomized, placebo-controlled trial of titrated intravenous lamifiban for acute coronary syndromes

Circulation

Volumn 105, Issue 3, 2002, Pages 316-321

  Harrington, Robert A ^a  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

Angina; Myocardial infarction; Platelets

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST; LAMIFIBAN; PLACEBO;

ADULT; AGED; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION; STEADY STATE; TITRIMETRY; TREATMENT OUTCOME;

ACETATES; ACUTE DISEASE; AGED; CORONARY DISEASE; DOUBLE-BLIND METHOD; ENDPOINT DETERMINATION; FEMALE; HEMORRHAGE; HUMANS; INCIDENCE; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; SYNDROME; TITRIMETRY; TREATMENT OUTCOME; TYROSINE;

EID: 0037154326     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/hc0302.102573     Document Type: Article

References (17)

1. Thrombosis in acute coronary syndromes and coronary interventions
2. Recognition of the importance of embolization in atherosclerotic vascular disease
3. Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb/IIIa integrin in ischemic heart disease
4. Assessment of the treatment effect of enoxaparin for unstable angina/non-Q-wave myocardial infarction
5. Effects of recombinant hirudin (lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation: A randomised trial
6. Inhibition of platelet glycoprotein IIb/lIIa with eptifibatide in patients with acute coronary syndromes
7. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina
8. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction
9. An international, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb/IIIa inhibitor), heparin, or both in unstable angina
10. Platelet membrane receptor glycoprotein Ilb/Illa antagonism in unstable angina: The Canadian lamifiban study
11. Patient-specific dosing of IIb/IlIa antagonists during acute coronary syndromes: Rationale and design of the PARAGON-B study
12. Prediction of creatinine clearance from serum creatinine
13. Systematic adjudication of myocardial infarction endpoints in an international clinical trial
14. Benefit of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes and troponin T-positive status: The PARAGON-B troponin T substudy
15. Acute coronary syndromes in the GUSTO-IIb trial: Prognostic insights and impact of recurrent ischemia
16. Relation between inhibition of platelet aggregation and clinical outcomes
17. Activated partial thromboplastin time and outcome after thrombolytic therapy for acute myocardial infarction: Results from the GUSTO-I trial